CD25 is also shown to be expressed in, BP-CML, BP-CML transformed in acute myeloid leukemia (AML) but also in de novo AML with dismal prognosis (13–19). Here, IL2RA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.